Skeletal complications to a TREM2 variant associated with Alzheimer's Disease

与阿尔茨海默病相关的 TREM2 变异的骨骼并发症

基本信息

  • 批准号:
    10618952
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

SUMMARY Alzheimer's disease (AD) is a growing health concern and is the most common type of dementia worldwide. Veterans who have been prisoners of war have a 50% greater risk to develop dementia later in life, a percentage that becomes even higher in veterans who develop posttraumatic stress disorder. Evidence indicates that mental illness and neurological and nervous system disorders can increase the risk of developing osteoporosis leading to high prevalence of bone fractures. Fractures, in particular of the hip, have been associated with increased mortality, especially in the elderly. Conversely, osteoporosis is associated with increased risk of dementia diag- nosis. In spite all this evidence, a direct link between dementia and osteoporosis, frequently occurring with aging, has never been conclusively demonstrated. Interestingly, some genetic mutations are risk factors for both AD and osteoporosis. As an example, mutations of the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is expressed in microglia in brain and in osteoclasts in bone correlate with AD and dementia, and with bone fragility. Recent studies led by Dr. Landreth, a Consultant in this application, showed that mice expressing the R47H TREM2 variant (TREM2R47H/+ mice) exhibit loss of TREM2 function and neuritic dystrophy. However, the mechanisms responsible for the TREM2 mutation effects on bone mass and strength are completely unclear. In our preliminary findings, we showed that aged 13-month-old female TREM2R47H/+ mice exhibit a skeletal pheno- type, with decreased cortical and cancellous bone mass and cortical bone biomechanical properties. In addition, female, but not male showed reduced bone mineral density accrual between 1 and 12 months of age. Work of others showed that low bone mass in TREM2-/- mice is ascribed to low osteoclast β-catenin activation, suggesting defective canonical Wnt signaling in the absence of TREM2 function. Consistent with this possibility, expression of Wnt target genes cyclin D1 and Cx43 in tibia is lower in TREM2R47H/+ compared to WT mice, whereas cyclin D1, Lef1 and Axin2 expression is reduced in osteoclastic cells derived from bone marrow cells isolated from TREM2R47H/+ mice. On the other hand, osteoclastic constitutive β-catenin activation or expression of a high bone mass (HMB) LRP5 mutant decreased osteoclasts and increased bone mass in mice. Yet, the cellular and mo- lecular mechanisms for the changes in the bone mass and composition in TREM2R47H/+ mice remain unknown. Further, the role of low Wnt signaling on the skeletal effect of the TREM2 variant has not been tested. Based on our preliminary studies and on published evidence we propose that reduced Wnt/β-catenin signaling due to abnormal TREM2 function leads to increased osteoclastic bone resorption and results in skeletal defi- ciencies. To test this hypothesis we will 1. Investigate whether abnormal TREM2 function worsens the conse- quences of sex steroid removal in male and female adult mice, 2. Determine whether deletion of osteoclastic TREM2 is sufficient to elicit the skeletal phenotype observed in TREM2R47H/+ mice, and 3. Determine the role of osteoclastic Wnt/β-catenin signaling in the bone phenotype resulting from TREM2 deficiency. Successful com- pletion of these studies will widen our understanding of the cellular and molecular basis of the skeletal defects in mice with increased susceptibility to develop AD. Further, it might set the basis for treatments to improve both the cognitive and skeletal deficits in AD patients.
总结 阿尔茨海默病(AD)是一个日益严重的健康问题,是世界上最常见的痴呆症类型。 曾经是战俘的退伍军人在以后的生活中患痴呆症的风险增加了50%, 在患创伤后应激障碍的退伍军人中,这一比例甚至更高。有证据表明, 疾病和神经和神经系统疾病可以增加患骨质疏松症的风险, 骨折的高发率。骨折,特别是髋关节骨折, 死亡率,尤其是老年人。相反,骨质疏松症与痴呆症诊断风险增加有关。 感觉。尽管有这些证据,痴呆症和骨质疏松症之间的直接联系,经常发生与衰老, 从未被证实。有趣的是,一些基因突变是AD的危险因素, 和骨质疏松症。例如,髓样细胞上表达的触发受体2(TREM 2)的突变 在脑中的小胶质细胞和骨中的破骨细胞中表达,与AD和痴呆相关,并且与骨 脆弱Landreth博士领导的最新研究表明,表达 R47 H TREM 2变体(TREM 2 R47 H/+小鼠)表现出TREM 2功能丧失和神经炎性营养不良。但 负责TREM 2突变对骨量和强度影响的机制完全不清楚。在 我们的初步研究结果表明,年龄为13个月的雌性TREM 2 R47 H/+小鼠表现出骨骼表型, 型,皮质骨和松质骨质量和皮质骨生物力学性能降低。此外,本发明还提供了一种方法, 女性,而不是男性,在1至12个月龄之间表现出降低的骨矿物质密度增加。工作 其他研究表明,TREM 2-/-小鼠的低骨量归因于低破骨细胞β-连环蛋白激活,这表明 在缺乏TREM 2功能的情况下有缺陷的典型Wnt信号传导。与这种可能性相一致, 与WT小鼠相比,TREM 2 R47 H/+小鼠胫骨中Wnt靶基因细胞周期蛋白D1和Cx43的表达较低,而细胞周期蛋白D1和Cx43的表达较低。 D1、Lef 1和Axin 2的表达在来源于分离自以下的骨髓细胞的成骨细胞中降低: TREM 2 R47 H/+小鼠。另一方面,成骨细胞组成性β-连环蛋白激活或高骨密度的表达, mass(HMB)LRP 5突变体减少破骨细胞并增加小鼠的骨量。然而,细胞和Mo- TREM 2 R47 H/+小鼠中骨量和组成变化的理论机制仍然未知。 此外,尚未测试低Wnt信号传导对TREM 2变体的骨骼效应的作用。基于 我们的初步研究和已发表的证据表明,Wnt/β-catenin信号转导的减少是由于 TREM 2功能异常导致骨细胞骨吸收增加,并导致骨骼缺陷。 科学为了验证这个假设,我们将1。调查TREM 2功能异常是否会导致 雄性和雌性成年小鼠中性类固醇去除的顺序,2.确定骨小梁是否缺失 TREM 2足以引发在TREM 2 R47 H/+小鼠中观察到的骨骼表型,以及3.确定的作用 TREM 2缺陷导致骨表型中的骨细胞Wnt/β-连环蛋白信号传导。成功的com- 这些研究将拓宽我们对骨骼缺损的细胞和分子基础的理解 对AD易感性增加的小鼠中。此外,它可能为改善这两种治疗方法奠定基础。 AD患者的认知和骨骼缺陷。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Musculoskeletal Deficits and Cognitive Impairment: Epidemiological Evidence and Biological Mechanisms.
Messages from the Mineral: How Bone Cells Communicate with Other Tissues.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lilian Irene Plotkin其他文献

Lilian Irene Plotkin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lilian Irene Plotkin', 18)}}的其他基金

Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
  • 批准号:
    10508931
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的影响
  • 批准号:
    10666647
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Contribution of chromosome versus gonadal sex to bone mass and strength
染色体与性腺性别对骨量和强度的贡献
  • 批准号:
    10711910
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10408018
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Skeletal complications to a TREM2 variant associated with Alzheimer's Disease
与阿尔茨海默病相关的 TREM2 变异的骨骼并发症
  • 批准号:
    10259555
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Osteocyte Apoptosis and Regulation of Bone Resorption with Aging
骨细胞凋亡和骨吸收随衰老的调节
  • 批准号:
    9212771
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Osteocyte apoptosis and regulation of bone resorption with aging
衰老过程中骨细胞凋亡和骨吸收的调节
  • 批准号:
    9308117
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    8049744
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    8241176
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Connexin 43 Hemichannels and Signaling In Bone
Connexin 43 半通道和骨信号传导
  • 批准号:
    7658224
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了